JM Melhem, J Detsky, MJ Lim-Fat,
JR Perry - Neurotherapeutics, 2022 - Elsevier
Glioblastoma is the most aggressive primary brain tumor with a poor prognosis. The 2021
WHO CNS5 classification has further stressed the importance of molecular signatures in …